Cargando…
Selective disruption of an oncogenic mutant allele by CRISPR/Cas9 induces efficient tumor regression
Approximately 15% of non-small cell lung cancer cases are associated with a mutation in the epidermal growth factor receptor (EGFR) gene, which plays a critical role in tumor progression. With the goal of treating mutated EGFR-mediated lung cancer, we demonstrate the use of clustered regularly inter...
Autores principales: | Koo, Taeyoung, Yoon, A-Rum, Cho, Hee-Yeon, Bae, Sangsu, Yun, Chae-Ok, Kim, Jin-Soo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5570104/ https://www.ncbi.nlm.nih.gov/pubmed/28575452 http://dx.doi.org/10.1093/nar/gkx490 |
Ejemplares similares
-
Selective targeting of the oncogenic KRAS G12S mutant allele by CRISPR/Cas9 induces efficient tumor regression
por: Gao, Qianqian, et al.
Publicado: (2020) -
CRISPR/Cas9 Editing of the Mutant Huntingtin Allele In Vitro and In Vivo
por: Monteys, Alex Mas, et al.
Publicado: (2017) -
Allele-specific genome editing using CRISPR–Cas9 is associated with loss of heterozygosity in diploid yeast
por: Gorter de Vries, Arthur R, et al.
Publicado: (2019) -
Selective targeting of KRAS oncogenic alleles by CRISPR/Cas9 inhibits proliferation of cancer cells
por: Lee, Wookjae, et al.
Publicado: (2018) -
Measuring and Reducing Off-Target Activities of Programmable Nucleases Including CRISPR-Cas9
por: Koo, Taeyoung, et al.
Publicado: (2015)